Back
Sarepta Therapeutics Vs. Polaris Industry Stock Comparison
Buy
70
SRPT
Sarepta Therapeutics
Last Price:
$20.57
Seasonality Move:
8.12%
Buy
52
PII
Polaris
Last Price:
$56.81
Seasonality Move:
3.38%
Buy
70
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $21.81. The Score for SRPT is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $21.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
PII Stock Price Chart
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.03 | Buy |
Relative Strength Index (14 RSI): | 61.42 | Buy |
Chaikin Money Flow: | 6597638 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
PII Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 13.94 | Buy |
Relative Strength Index (14 RSI): | 62.06 | Buy |
Chaikin Money Flow: | -939285 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.96 | Buy |
20-day SMA: | 16.47 | Buy |
50-day SMA: | 20.62 | Buy |
200-day SMA: | 75.35 | Sell |
8-day EMA: | 18.91 | Buy |
20-day EMA: | 13.99 | Buy |
50-day EMA: | 7.79 | Buy |
200-day EMA: | 2.35 | Buy |
PII Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.91 | Buy |
20-day SMA: | 52.89 | Buy |
50-day SMA: | 47.32 | Buy |
200-day SMA: | 49.32 | Buy |
8-day EMA: | 54.19 | Buy |
20-day EMA: | 41.22 | Buy |
50-day EMA: | 23.26 | Buy |
200-day EMA: | 7.06 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.34 per share, an increase next quarter of $1.27 per share, a decrease this year of $5.65 per share, and an increase next year of $5.32 per share.
Polaris Earnings Growth & PII Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.06 per share, an increase next quarter of $0.49 per share, a decrease this year of $3.74 per share, and an increase next year of $1.57 per share.
Sarepta Therapeutics Technical Analysis
Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Polaris Technical Analysis
Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |